| Penetration of bevacizumab through the retina after intravitreal injection in the monkey P Heiduschka, H Fietz, S Hofmeister, S Schultheiss, AF Mack, S Peters, ... Investigative ophthalmology & visual science 48 (6), 2814-2823, 2007 | 339 | 2007 |
| A swarm of slippery micropropellers penetrates the vitreous body of the eye Z Wu, J Troll, HH Jeong, Q Wei, M Stang, F Ziemssen, Z Wang, M Dong, ... Science advances 4 (11), eaat4388, 2018 | 289 | 2018 |
| Intracameral bevacizumab for iris rubeosis S Grisanti, S Biester, S Peters, O Tatar, F Ziemssen, KU Bartz-Schmidt, ... American journal of ophthalmology 142 (1), 158-160, 2006 | 257 | 2006 |
| Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab S Peters, P Heiduschka, S Julien, F Ziemssen, H Fietz, KU Bartz-Schmidt, ... American journal of ophthalmology 143 (6), 995-1002. e2, 2007 | 251 | 2007 |
| Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ... The Lancet Neurology 16 (3), 189-199, 2017 | 207 | 2017 |
| Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn E Yoeruek, F Ziemssen, S Henke‐Fahle, O Tatar, A Tura, S Grisanti, ... Acta Ophthalmologica 86 (3), 322-328, 2008 | 188 | 2008 |
| Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization Q Zhu, F Ziemssen, S Henke-Fahle, O Tatar, P Szurman, S Aisenbrey, ... Ophthalmology 115 (10), 1750-1755. e1, 2008 | 179 | 2008 |
| Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration S Aisenbrey, F Ziemssen, M Völker, F Gelisken, P Szurman, G Jaissle, ... Graefe's Archive for Clinical and Experimental Ophthalmology 245 (7), 941-948, 2006 | 139 | 2006 |
| One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion GB Jaissle, M Leitritz, F Gelisken, F Ziemssen, KU Bartz-Schmidt, ... Graefe's Archive for Clinical and Experimental Ophthalmology 247 (1), 27-33, 2009 | 137 | 2009 |
| Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema MS Spitzer, F Ziemssen, E Yoeruek, K Petermeier, S Aisenbrey, ... Journal of Cataract & Refractive Surgery 34 (1), 70-75, 2008 | 134 | 2008 |
| Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study S Grisanti, P Szurman, M Warga, R Kaczmarek, F Ziemssen, O Tatar, ... Investigative ophthalmology & visual science 46 (1), 191-196, 2005 | 122 | 2005 |
| The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) T Ziemssen, F Ziemssen Autoimmunity reviews 4 (7), 460-467, 2005 | 115 | 2005 |
| Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use PJ Patel, F Ziemssen, E Ng, A Muthutantri, D Silverman, EA Tschosik, ... Clinical Ophthalmology (Auckland, NZ) 14, 15, 2020 | 101 | 2020 |
| Bevacizumab for treatment of macular edema secondary to retinal vein occlusion GB Jaissle, F Ziemssen, K Petermeier, P Szurman, M Ladewig, F Gelisken, ... Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft …, 2006 | 101 | 2006 |
| A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation M Vorgerd, K Ricker, F Ziemssen, W Kress, HH Goebel, WA Nix, ... Neurology 57 (12), 2273-2277, 2001 | 94 | 2001 |
| Bevacizumab: off-label use in ophthalmology S Grisanti, F Ziemssen Indian journal of ophthalmology 55 (6), 417, 2007 | 87 | 2007 |
| Effects of bevacizumab on retinal function in isolated vertebrate retina M Lüke, M Warga, F Ziemssen, F Gelisken, S Grisanti, T Schneider, ... British journal of ophthalmology 90 (9), 1178-1182, 2006 | 85 | 2006 |
| Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization AM Mansour, JF Arevalo, F Ziemssen, A Mehio-Sibai, F Mackensen, ... American journal of ophthalmology 148 (2), 310-316. e2, 2009 | 83 | 2009 |
| Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability S Peters, IA Cree, R Alexander, P Turowski, Z Ockrim, J Patel, SR Boyd, ... Cytokine 40 (2), 144-150, 2007 | 76 | 2007 |
| Intravitreal bevacizumab in inflammatory ocular neovascularization AM Mansour, F Mackensen, JF Arevalo, F Ziemssen, P Mahendradas, ... American journal of ophthalmology 146 (3), 410-416. e1, 2008 | 75 | 2008 |
Tjalf ZiemssenUKDVerified email at uniklinikum-dresden.de
